Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Rachel G, Liao"'
Autor:
Melissa S Cline, Rachel G Liao, Michael T Parsons, Benedict Paten, Faisal Alquaddoomi, Antonis Antoniou, Samantha Baxter, Larry Brody, Robert Cook-Deegan, Amy Coffin, Fergus J Couch, Brian Craft, Robert Currie, Chloe C Dlott, Lena Dolman, Johan T den Dunnen, Stephanie O M Dyke, Susan M Domchek, Douglas Easton, Zachary Fischmann, William D Foulkes, Judy Garber, David Goldgar, Mary J Goldman, Peter Goodhand, Steven Harrison, David Haussler, Kazuto Kato, Bartha Knoppers, Charles Markello, Robert Nussbaum, Kenneth Offit, Sharon E Plon, Jem Rashbass, Heidi L Rehm, Mark Robson, Wendy S Rubinstein, Dominique Stoppa-Lyonnet, Sean Tavtigian, Adrian Thorogood, Can Zhang, Marc Zimmermann, BRCA Challenge Authors, John Burn, Stephen Chanock, Gunnar Rätsch, Amanda B Spurdle
Publikováno v:
PLoS Genetics, Vol 14, Iss 12, p e1007752 (2018)
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Genomics and Health (GA4GH) to aggregate BRCA1 and BRCA2 data to support highly collaborative research activities. Its goal is to generate an informed and
Externí odkaz:
https://doaj.org/article/3d040669de2049168c109d5c746eac9a
Autor:
Adam J. Bass, Peter S. Hammerman, Matthew Meyerson, Nathanael S. Gray, David J. Kwiatkowski, Geoffrey I. Shapiro, Therese Ovesen, Changhong Miao, Yanxi Zhang, Tianxia Li, Aaron R. Thorner, Li Tan, Jun Wang, Federica Piccioni, Yvonne Li, Rachel G. Liao, Wankun Chen, Maria Rusan, Bruno Bockorny
Figure S1 shows sensitivity of NCI-H2077 cells to FGFR inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cf9b3bcfc7dc757c7883d2394ea7af1
https://doi.org/10.1158/1535-7163.22505596
https://doi.org/10.1158/1535-7163.22505596
Autor:
Adam J. Bass, Peter S. Hammerman, Matthew Meyerson, Nathanael S. Gray, David J. Kwiatkowski, Geoffrey I. Shapiro, Therese Ovesen, Changhong Miao, Yanxi Zhang, Tianxia Li, Aaron R. Thorner, Li Tan, Jun Wang, Federica Piccioni, Yvonne Li, Rachel G. Liao, Wankun Chen, Maria Rusan, Bruno Bockorny
Supplementary Table 1 and 2 describe pharmacologic properties of BGJ398 and FIIN-3 and Supplementary Table 4 describes the characteristics of cellular models employed in the colony formation assays.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d3d98c90c255863ef33df552c22f95
https://doi.org/10.1158/1535-7163.22505578.v1
https://doi.org/10.1158/1535-7163.22505578.v1
Autor:
Adam J. Bass, Peter S. Hammerman, Matthew Meyerson, Nathanael S. Gray, David J. Kwiatkowski, Geoffrey I. Shapiro, Therese Ovesen, Changhong Miao, Yanxi Zhang, Tianxia Li, Aaron R. Thorner, Li Tan, Jun Wang, Federica Piccioni, Yvonne Li, Rachel G. Liao, Wankun Chen, Maria Rusan, Bruno Bockorny
Supplement Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19127759328ae1575e6b8ea6037d544d
https://doi.org/10.1158/1535-7163.22505581.v1
https://doi.org/10.1158/1535-7163.22505581.v1
Autor:
Adam J. Bass, Peter S. Hammerman, Matthew Meyerson, Nathanael S. Gray, David J. Kwiatkowski, Geoffrey I. Shapiro, Therese Ovesen, Changhong Miao, Yanxi Zhang, Tianxia Li, Aaron R. Thorner, Li Tan, Jun Wang, Federica Piccioni, Yvonne Li, Rachel G. Liao, Wankun Chen, Maria Rusan, Bruno Bockorny
Figure S2 shows ORF screen for resistance to FGFR inhibition and Figure S3 shows candidate mediators of resistance to FGFR inhibition based on ORF screen.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206405b00a388610585040eee66088df
https://doi.org/10.1158/1535-7163.22505593
https://doi.org/10.1158/1535-7163.22505593
Autor:
Adam J. Bass, Peter S. Hammerman, Matthew Meyerson, Nathanael S. Gray, David J. Kwiatkowski, Geoffrey I. Shapiro, Therese Ovesen, Changhong Miao, Yanxi Zhang, Tianxia Li, Aaron R. Thorner, Li Tan, Jun Wang, Federica Piccioni, Yvonne Li, Rachel G. Liao, Wankun Chen, Maria Rusan, Bruno Bockorny
Supplementary Table 3 shows top 2500 upregulated genes for each cluster utilized for pathway enrichment analysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc797997582adbadd8426c248e316d3
https://doi.org/10.1158/1535-7163.22505575
https://doi.org/10.1158/1535-7163.22505575
Autor:
Adam J. Bass, Peter S. Hammerman, Matthew Meyerson, Nathanael S. Gray, David J. Kwiatkowski, Geoffrey I. Shapiro, Therese Ovesen, Changhong Miao, Yanxi Zhang, Tianxia Li, Aaron R. Thorner, Li Tan, Jun Wang, Federica Piccioni, Yvonne Li, Rachel G. Liao, Wankun Chen, Maria Rusan, Bruno Bockorny
The FGFR kinases are promising therapeutic targets in multiple cancer types, including lung and head and neck squamous cell carcinoma, cholangiocarcinoma, and bladder cancer. Although several FGFR kinase inhibitors have entered clinical trials, singl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::172bc45ec2a1973c90b2a3ca921ffcb5
https://doi.org/10.1158/1535-7163.c.6538123.v1
https://doi.org/10.1158/1535-7163.c.6538123.v1
Autor:
Kwok-Kin Wong, Peter S. Hammerman, Matthew Meyerson, Lynette M. Sholl, Roderick T. Bronson, Rachel G. Liao, Kevin Rhee, Eiki Kikuchi, Oliver R. Mikse, Abigail Altabef, Esra A. Akbay, Jeremy H. Tchaicha
Somatic mutations in FGFR2 are present in 4% to 5% of patients diagnosed with non–small cell lung cancer (NSCLC). Amplification and mutations in FGFR genes have been identified in patients with NSCLCs, and clinical trials are testing the efficacy o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b37e72a8b34f183bd1555e3b37e4dac7
https://doi.org/10.1158/0008-5472.c.6505853
https://doi.org/10.1158/0008-5472.c.6505853
Autor:
Peter S. Hammerman, Matthew Meyerson, Robert I. Haddad, Kwok-Kin Wong, Gad Getz, Nathanael S. Gray, D. Neil Hayes, Chandra Sekhar Pedamallu, Trevor J. Pugh, Qingsong Liu, Ellen M. Beauchamp, Andrey Sivachenko, Matthew D. Wilkerson, Jeremy Tchaicha, Joonil Jung, Rachel G. Liao
A comprehensive description of genomic alterations in lung squamous cell carcinoma (lung SCC) has recently been reported, enabling the identification of genomic events that contribute to the oncogenesis of this disease. In lung SCC, one of the most f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79a2d659ab57fc5cdb68f822dad89ade
https://doi.org/10.1158/0008-5472.c.6505725
https://doi.org/10.1158/0008-5472.c.6505725
Autor:
Peter S. Hammerman, Matthew Meyerson, Robert I. Haddad, Kwok-Kin Wong, Gad Getz, Nathanael S. Gray, D. Neil Hayes, Chandra Sekhar Pedamallu, Trevor J. Pugh, Qingsong Liu, Ellen M. Beauchamp, Andrey Sivachenko, Matthew D. Wilkerson, Jeremy Tchaicha, Joonil Jung, Rachel G. Liao
PDF file - 159K, Ba/F3 data with six additional inhibitors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00b6d563137e1384903aabd939d0c0a4
https://doi.org/10.1158/0008-5472.22400934
https://doi.org/10.1158/0008-5472.22400934